Shopping Cart
Remove All
Your shopping cart is currently empty
Puxitatugsamrotecan (AZD8205) is an antibody-drug conjugate (ADC) targeting B7-H4. It is formed by conjugating the Puxitatug antibody, which targets B7-H4, with the Puxitatug samrotecan drug-linker through random conjugation by reducing interchain cysteine. Puxitatug samrotecan exhibits antitumor activity and can be utilized in the study of cancers expressing B7-H4.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | Puxitatugsamrotecan (AZD8205) is an antibody-drug conjugate (ADC) targeting B7-H4. It is formed by conjugating the Puxitatug antibody, which targets B7-H4, with the Puxitatug samrotecan drug-linker through random conjugation by reducing interchain cysteine. Puxitatug samrotecan exhibits antitumor activity and can be utilized in the study of cancers expressing B7-H4. |
| Synonyms | AZD 8205 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Target | B7-H4 |
| Cas No. | 2760250-80-2 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.